SCHEMBL24359763

SCHEMBL24359763

CCc1cccc(-c2ccn(C)n2)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.50
▸ GABRB2 P47870 2/20 0.50
▸ CASP6 P55212 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GRM5 P41594 1/20 0.39
▸ TGFBR1 P36897 1/20 0.39
▸ PTPN5 P54829 1/20 0.39
▸ HSD17B13 Q7Z5P4 1/20 0.38
▸ LTB4R Q15722 1/20 0.38
▸ ANPEP P15144 1/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ HAO1 Q9UJM8 1/20 0.36
▸ MAPK8 P45983 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ MPO P05164 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ JMJD6 Q6NYC1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9289349 0.83 KMT2A (0.50) CASP6KMT2AGRM5TGFBR1HSD17B13
SCHEMBL19589424 0.82 MPO (0.46) GABRA1GABRB2CASP6KMT2AGRM5
SCHEMBL17198955 0.78 TYK2 (0.40) KMT2AGRM5ADRA1DADRA1AADRA1B
SCHEMBL16527783 0.76 GABRA1 (0.76) GABRA1GABRB2PTPN5ANPEPDPP4
SCHEMBL23108234 0.76 ERN1 (0.44) CASP6KMT2ATGFBR1ADRA1DADRA1A
SCHEMBL24359769 0.75 GABRA1 (0.47) GABRA1GABRB2PTPN5ANPEPDPP4
SCHEMBL1095492 0.73 KMT2A (0.55) CASP6KMT2ATGFBR1ADRA1DADRA1A
SCHEMBL30117290 0.72 GABRA1 (0.61) GABRA1GABRB2PTPN5ANPEPDPP4
Hydrochloric Acid SCHEMBL30549511 0.72 KMT2A (0.53) CASP6KMT2ATGFBR1ADRA1DADRA1A
SCHEMBL28968048 0.72 GABRA1 (0.61) GABRA1GABRB2PTPN5ANPEPDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495358-B1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL MYERS SQUIBB CO (US) 2022-04-27 — — EP disclosed
Send feedback